Noemi Dala-Kiss

Üllői Street 26
Budapest, BU 1085, Hungary

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Secondary infections and long-term outcomes among hospitalized elderly and non-elderly patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and treated with baricitinib: a comparative study from the national centre of Hungary.

Secondary infections and long-term outcomes among hospitalized elderly and non-elderly patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and treated with baricitinib: a comparative study from the national centre of Hungary.

Journal: GeroScience

Published: September 10, 2023

Outcomes of high-risk adult outpatients treated with early remdesivir therapy during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) omicron era: experiences from the national centre of Hungary.

Outcomes of high-risk adult outpatients treated with early remdesivir therapy during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) omicron era: experiences from the national centre of Hungary.

Journal: Naunyn-Schmiedeberg's archives of pharmacology

Published: November 20, 2022

Baricitinib vs tocilizumab treatment for hospitalized adult patients with severe COVID-19 and associated cytokine storm: a prospective, investigational, real-world study.

Baricitinib vs tocilizumab treatment for hospitalized adult patients with severe COVID-19 and associated cytokine storm: a prospective, investigational, real-world study.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: August 31, 2022

Use of convalescent plasma therapy in hospitalised adult patients with non-critical COVID-19: a focus on the elderly from Hungary.

Use of convalescent plasma therapy in hospitalised adult patients with non-critical COVID-19: a focus on the elderly from Hungary.

Journal: GeroScience

Published: June 09, 2022

COVID–19-associated liver enzyme elevation is probably multifactorial

COVID–19-associated liver enzyme elevation is probably multifactorial

Journal: Orvosi hetilap

Published: May 29, 2022

Laboratory parameters predicting mortality of adult in-patients with COVID-19 associated cytokine release syndrome treated with high-dose tocilizumab.

Laboratory parameters predicting mortality of adult in-patients with COVID-19 associated cytokine release syndrome treated with high-dose tocilizumab.

Journal: Acta microbiologica et immunologica Hungarica

Published: July 01, 2021

A COVID-19-association-dependent categorization of death causes in 100 autopsy cases.

A COVID-19-association-dependent categorization of death causes in 100 autopsy cases.

Journal: GeroScience

Published: June 10, 2021

Favipiravir treatment does not influence disease progression among adult patients hospitalized with moderate-to-severe COVID-19: a prospective, sequential cohort study from Hungary.

Favipiravir treatment does not influence disease progression among adult patients hospitalized with moderate-to-severe COVID-19: a prospective, sequential cohort study from Hungary.

Journal: GeroScience

Published: June 05, 2021

Showing 1-8 of 8

Last Updated: 09/26/2026